more about managing osteoporosis and promoting adherence with "bisphosphonate" meds (alendronate, etc)

You'll hear more about managing osteoporosis and promoting adherence with "bisphosphonate" meds (alendronate, etc).

About 50% of patients on a bisphosphonate stop after one year...due to side effects, cost, dosing schedules, or not feeling the drug working.

This can lead to worsening bone loss...and fractures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote